{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:07:31Z","timestamp":1787166451150,"version":"build-2736575974"},"reference-count":120,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The increasing global burden of cardiometabolic diseases highlights the urgent clinical need for better personalized prediction and intervention strategies. Early diagnosis and prevention could greatly reduce the enormous socio-economic burden posed by these states. Plasma lipids including total cholesterol, triglycerides, HDL-C, and LDL-C have been at the center stage of the prediction and prevention strategies for cardiovascular disease; however, the bulk of cardiovascular disease events cannot be explained sufficiently by these lipid parameters. The shift from traditional serum lipid measurements that are poorly descriptive of the total serum lipidomic profile to comprehensive lipid profiling is an urgent need, since a wealth of metabolic information is currently underutilized in the clinical setting. The tremendous advances in the field of lipidomics in the last two decades has facilitated the research efforts to unravel the lipid dysregulation in cardiometabolic diseases, enabling the understanding of the underlying pathophysiological mechanisms and identification of predictive biomarkers beyond traditional lipids. This review presents an overview of the application of lipidomics in the study of serum lipoproteins in cardiometabolic diseases. Integrating the emerging multiomics with lipidomics holds great potential in moving toward this goal.<\/jats:p>","DOI":"10.3390\/diagnostics13040721","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T03:37:24Z","timestamp":1676432244000},"page":"721","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expanding the Molecular Disturbances of Lipoproteins in Cardiometabolic Diseases: Lessons from Lipidomics"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-1323","authenticated-orcid":false,"given":"Christina E.","family":"Kostara","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Chemistry, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMra1104901","article-title":"The human plasma lipidome","volume":"365","author":"Quehenberger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11883-010-0100-0","article-title":"Lipidomics as a tool for the study of lipoprotein metabolism","volume":"12","author":"Kontush","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ding, M., and Rexrode, K.M. (2020). A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins. Metabolites, 10.","DOI":"10.3390\/metabo10040163"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pietilainen, K.H., Sysi-Aho, M., Rissanen, A., Seppanen-Laakso, T., Yki-Jarvinen, H., Kaprio, J., and Oresic, M. (2007). Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000218"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yetukuri, L., Katajamaa, M., Medina-Gomez, G., Seppanen-Laakso, T., Vidal-Puig, A., and Oresic, M. (2007). Bioinformatics strategies for lipidomics analysis: Characterization of obesity related hepatic steatosis. BMC Syst. Biol., 1.","DOI":"10.1186\/1752-0509-1-12"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-61-5-888","article-title":"Risk Factors in Coronary Heart Disease. An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease; the Framingham Study","volume":"61","author":"Kannel","year":"1964","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/bbrc.2001.4404","article-title":"Nondestructive quantification of neutral lipids by thin-layer chromatography and laser-fluorescent scanning: Suitable methods for \u201clipidome\u201d analysis","volume":"281","author":"Kishimoto","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1194\/jlr.R300004-JLR200","article-title":"Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: A bridge to lipidomics","volume":"44","author":"Han","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0076-6879(07)32007-7","article-title":"The lipid maps initiative in lipidomics","volume":"432","author":"Schmelzer","year":"2007","journal-title":"Methods Enzymol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbalip.2011.06.009","article-title":"Lipid classification, structures and tools","volume":"1811","author":"Fahy","year":"2011","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_15","first-page":"68","article-title":"The key points in the pre-analytical procedures of blood and urine samples in metabolomics studies","volume":"16","author":"Bi","year":"2020","journal-title":"Metab. Off. J. Metab. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"D527","DOI":"10.1093\/nar\/gkl838","article-title":"LMSD: LIPID MAPS structure database","volume":"35","author":"Sud","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40169-017-0152-7","article-title":"Biofluid lipidome: A source for potential diagnostic biomarkers","volume":"6","author":"Ghosh","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.aca.2020.08.061","article-title":"Determination of one year stability of lipid plasma profile and comparison of blood collection tubes using UHPSFC\/MS and HILIC-UHPLC\/MS","volume":"1137","author":"Wolrab","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14468","DOI":"10.1073\/pnas.1222647110","article-title":"Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans","volume":"110","author":"Chua","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4155\/bio.15.16","article-title":"The influence of sample collection methodology and sample preprocessing on the blood metabolic profile","volume":"7","author":"Jorgenrud","year":"2015","journal-title":"Bioanalysis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clinbiochem.2015.02.004","article-title":"The effect of haemolysis on the metabolomic profile of umbilical cord blood","volume":"48","author":"Denihan","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2014.04.042","article-title":"Non-enzymatic lipid oxidation products in biological systems: Assessment of the metabolites from polyunsaturated fatty acids","volume":"964","author":"Vigor","year":"2014","journal-title":"J. Chromatography. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2013.12.030","article-title":"Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage","volume":"449","author":"Barden","year":"2014","journal-title":"Anal. Biochem."},{"key":"ref_24","first-page":"507","article-title":"Effects of sample handling and storage on quantitative lipid analysis in human serum","volume":"5","author":"Zivkovic","year":"2009","journal-title":"Metab. Off. J. Metab. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-2275(20)35367-0","article-title":"Heterogeneity of serum low density lipoproteins in normal human subjects","volume":"22","author":"Shen","year":"1981","journal-title":"J. Lipid Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1194\/jlr.D300003-JLR200","article-title":"Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent","volume":"44","author":"Hirowatari","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0022-2275(20)38295-X","article-title":"Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels","volume":"30","author":"Verdery","year":"1989","journal-title":"J. Lipid Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/pr900783x","article-title":"Evaluation of established coronary heart disease on the basis of HDL and non-HDL NMR lipid profiling","volume":"9","author":"Kostara","year":"2010","journal-title":"J. Proteome Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.copbio.2016.11.008","article-title":"Recent advances in expanding the coverage of the lipidome","volume":"43","author":"Tumanov","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Saini, R.K., Prasad, P., Shang, X., and Keum, Y.S. (2021). Advances in Lipid Extraction Methods-A Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413643"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Aldana, J., Romero-Otero, A., and Cala, M.P. (2020). Exploring the Lipidome: Current Lipid Extraction Techniques for Mass Spectrometry Analysis. Metabolites, 10.","DOI":"10.3390\/metabo10060231"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1194\/jlr.D050302","article-title":"A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids","volume":"55","author":"Lydic","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1194\/jlr.M044826","article-title":"Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles","volume":"55","author":"Lam","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/bmc.3683","article-title":"Extraction, chromatographic and mass spectrometric methods for lipid analysis","volume":"30","author":"Pati","year":"2016","journal-title":"Biomed. Chromatogr. BMC"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/chromsci\/13.9.407","article-title":"High pressure liquid chromatography of fatty acids and lipids","volume":"13","author":"Cooper","year":"1975","journal-title":"J. Chromatogr. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9673(00)80538-5","article-title":"Isocratic high-performance liquid chromatography separation of phosphoglycerides and lysophosphoglycerides","volume":"197","author":"Gross","year":"1980","journal-title":"J. Chromatogr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jchromb.2009.05.004","article-title":"Improved separation and quantification of neutral and polar lipid classes by HPLC-ELSD using a monolithic silica phase: Application to exceptional marine lipids","volume":"877","author":"Graeve","year":"2009","journal-title":"J. Chromatography. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/ac403554h","article-title":"Analytical methods in lipidomics and their applications","volume":"86","author":"Li","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/10408347.2017.1310613","article-title":"Analytical Techniques in Lipidomics: State of the Art","volume":"47","author":"Jurowski","year":"2017","journal-title":"Crit. Rev. Anal. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jssc.201700709","article-title":"Mass-spectrometry-based lipidomics","volume":"41","author":"Hu","year":"2018","journal-title":"J. Sep. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trac.2014.04.017","article-title":"Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry","volume":"61","author":"Cajka","year":"2014","journal-title":"Trends Anal. Chem. TRAC"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1007\/s00216-018-1252-y","article-title":"Mass spectrometry-based shotgun lipidomics\u2014A critical review from the technical point of view","volume":"410","author":"Hsu","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mas.10046","article-title":"Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids","volume":"22","author":"Griffiths","year":"2003","journal-title":"Mass Spectrom. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mas.10061","article-title":"Electrospray mass spectrometry of phospholipids","volume":"22","author":"Pulfer","year":"2003","journal-title":"Mass Spectrom. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mas.20023","article-title":"Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples","volume":"24","author":"Han","year":"2005","journal-title":"Mass Spectrom. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M700440-JLR200","article-title":"A rapid approach to lipid profiling of mycobacteria using 2D HSQC NMR maps","volume":"49","author":"Mahrous","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.copbio.2016.08.004","article-title":"Multidimensional NMR approaches towards highly resolved, sensitive and high-throughput quantitative metabolomics","volume":"43","author":"Marchand","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1021\/ac500966e","article-title":"Evaluation of fast 2D NMR for metabolomics","volume":"86","author":"Guennec","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.162.3856.909","article-title":"Structure of human serum lipoproteins: Nuclear magnetic resonance supports a micellar model","volume":"162","author":"Steim","year":"1968","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12944-020-01424-2","article-title":"The extended lipid panel assay: A clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B","volume":"19","author":"Garcia","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial","volume":"113","author":"Otvos","year":"2006","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1099-1492(199806\/08)11:4\/5<168::AID-NBM527>3.0.CO;2-K","article-title":"Application of self-organizing maps for the detection and classification of human blood plasma lipoprotein lipid profiles on the basis of 1H NMR spectroscopy data","volume":"11","author":"Kaartinen","year":"1998","journal-title":"NMR Biomed."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0003-2697(89)90358-8","article-title":"Analysis of membrane lipids by 500 MHz 1H NMR","volume":"178","author":"Sparling","year":"1989","journal-title":"Anal. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0022-2275(20)39939-9","article-title":"NMR lipid profiles of cells, tissues, and body fluids: Proton NMR analysis of human erythrocyte lipids","volume":"35","author":"Adosraku","year":"1994","journal-title":"J. Lipid Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0167-4889(90)90241-5","article-title":"Characterization of lipid composition in stimulated human lymphocytes by 1H-NMR","volume":"1054","author":"Sze","year":"1990","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1006\/bbrc.1993.1546","article-title":"1H NMR spectroscopic studies of lipid extracts from human fatty liver","volume":"192","author":"Pollesello","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","first-page":"169","article-title":"Evaluation of the lipid composition of human healthy and neoplastic renal tissues","volume":"53","author":"Tugnoli","year":"2004","journal-title":"Ital. J. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1388-1981(00)00078-0","article-title":"1H-NMR lipid profiles of human blood platelets; links with coronary artery disease","volume":"1487","author":"Noula","year":"2000","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.jchromb.2009.01.025","article-title":"Bioinformatics and computational methods for lipidomics","volume":"877","author":"Niemela","year":"2009","journal-title":"J. Chromatography. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kostara, C.E., Ferrannini, E., Bairaktari, E.T., Papathanasiou, A., Elisaf, M., and Tsimihodimos, V. (2020). Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228835"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1194\/jlr.M009449","article-title":"Lipidomics reveals a remarkable diversity of lipids in human plasma","volume":"51","author":"Quehenberger","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1021\/acs.jproteome.7b00236","article-title":"Comprehensive Lipoprotein Characterization Using Lipidomics Analysis of Human Plasma","volume":"16","author":"Christinat","year":"2017","journal-title":"J. Proteome Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5551\/jat.E571","article-title":"Antiatherogenic functionality of high density lipoprotein: How much versus how good","volume":"15","author":"Sviridov","year":"2008","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"26910","DOI":"10.1074\/jbc.270.45.26910","article-title":"Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability","volume":"270","author":"Sparks","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1021\/bi992902m","article-title":"The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: A surface plasmon resonance study","volume":"39","author":"Curtiss","year":"2000","journal-title":"Biochemistry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1194\/jlr.M100431-JLR200","article-title":"LDL and HDL enriched in triglyceride promote abnormal cholesterol transport","volume":"43","author":"Skeggs","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(99)00098-4","article-title":"HDL metabolism in hypertriglyceridemic states: An overview","volume":"286","author":"Lamarche","year":"1999","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-2275(20)31997-0","article-title":"Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high density lipoproteins","volume":"41","author":"Rye","year":"2000","journal-title":"J. Lipid Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1194\/jlr.M300231-JLR200","article-title":"In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux","volume":"45","author":"Yancey","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-2275(20)33434-9","article-title":"Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression","volume":"41","author":"Baker","year":"2000","journal-title":"J. Lipid Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/sj.ijo.0800524","article-title":"Lipoprotein distribution and composition in obesity: Their association with central adiposity","volume":"21","author":"James","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/pr.2013.93","article-title":"High-density lipoprotein subfractions display proatherogenic properties in overweight and obese children","volume":"74","author":"McEneny","year":"2013","journal-title":"Pediatr. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1476-511X-10-176","article-title":"New insights into the mechanism of low high-density lipoprotein cholesterol in obesity","volume":"10","author":"Wang","year":"2011","journal-title":"Lipids Health Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Stadler, J.T., Lackner, S., Morkl, S., Trakaki, A., Scharnagl, H., Borenich, A., Wonisch, W., Mangge, H., Zelzer, S., and Meier-Allard, N. (2021). Obesity Affects HDL Metabolism, Composition and Subclass Distribution. Biomedicines, 9.","DOI":"10.3390\/biomedicines9030242"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/2230-8210.111618","article-title":"Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia","volume":"17","author":"Kota","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/ATVBAHA.117.309287","article-title":"Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment","volume":"37","author":"Denimal","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/ATVBAHA.115.307049","article-title":"Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection","volume":"36","author":"Brinck","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ncpcardio0500","article-title":"Antiatherogenic small, dense HDL--guardian angel of the arterial wall?","volume":"3","author":"Kontush","year":"2006","journal-title":"Nat. Clin. Practice. Cardiovasc. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","article-title":"Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: Relationship to elevated oxidative stress and hyperglycaemia","volume":"48","author":"Nobecourt","year":"2005","journal-title":"Diabetologia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/01.ATV.19.9.2226","article-title":"Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL","volume":"19","author":"Gowri","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: Relevance to inflammation and atherogenesis","volume":"29","author":"Therond","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11892-008-0010-5","article-title":"Why is HDL functionally deficient in type 2 diabetes?","volume":"8","author":"Kontush","year":"2008","journal-title":"Curr. Diabetes Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erc.11.182","article-title":"HDL dysfunction in diabetes: Causes and possible treatments","volume":"10","author":"Farbstein","year":"2012","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Vaisar, T., Couzens, E., Hwang, A., Russell, M., Barlow, C.E., DeFina, L.F., Hoofnagle, A.N., and Kim, F. (2018). Type 2 diabetes is associated with loss of HDL endothelium protective functions. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192616"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1314864","DOI":"10.1155\/2017\/1314864","article-title":"Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL(2) and HDL(3)","volume":"2017","author":"Griffiths","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kostara, C.E., Karakitsou, K.S., Florentin, M., Bairaktari, E.T., and Tsimihodimos, V. (2022). Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes. Metabolites, 12.","DOI":"10.3390\/metabo12080683"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1472-8206.2009.00739.x","article-title":"Lipid modification in type 2 diabetes: The role of LDL and HDL","volume":"23","author":"Verges","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.116.307385","article-title":"Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report","volume":"36","author":"Apro","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diabres.2008.01.018","article-title":"HbA1c negatively correlates with LCAT activity in type 2 diabetes","volume":"81","author":"Nakhjavani","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: A high-risk state for diabetes development","volume":"379","author":"Tabak","year":"2012","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","article-title":"Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)","volume":"116","author":"Barr","year":"2007","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J. Hepatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n-6\/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Perla, F.M., Prelati, M., Lavorato, M., Visicchio, D., and Anania, C. (2017). The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. Children, 4.","DOI":"10.3390\/children4060046"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr. Diabetes"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Lin, X., Liu, X., Triba, M.N., Bouchemal, N., Liu, Z., Walker, D.I., Palama, T., Le Moyec, L., Ziol, M., and Helmy, N. (2022). Plasma Metabolomic and Lipidomic Profiling of Metabolic Dysfunction-Associated Fatty Liver Disease in Humans Using an Untargeted Multiplatform Approach. Metabolites, 12.","DOI":"10.3390\/metabo12111081"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"New Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.jrn.2013.01.022","article-title":"Role of HDL dysfunction in end-stage renal disease: A double-edged sword","volume":"23","author":"Moradi","year":"2013","journal-title":"J. Ren. Nutr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0272-6386(00)70255-1","article-title":"Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation","volume":"35","author":"Deighan","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2008.11.007","article-title":"Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease","volume":"153","author":"Moradi","year":"2009","journal-title":"Transl. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5551\/jat.30015","article-title":"High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease","volume":"23","author":"Honda","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"Tolle","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"212525","DOI":"10.7573\/dic.212525","article-title":"High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease","volume":"7","author":"Kosmas","year":"2018","journal-title":"Drugs Context"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjcard.2015.11.033","article-title":"Prognostic Usefulness of Serum Cholesterol Efflux Capacity in Patients With Coronary Artery Disease","volume":"117","author":"Zhang","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Hama","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_116","first-page":"101","article-title":"HDL-cholesterol concentration and severity of coronary atherosclerosis determined by cine-angiography","volume":"8","author":"Naito","year":"1980","journal-title":"Artery"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2003.10.015","article-title":"The significance of serum HDL phospholipid levels in angiographically defined coronary artery disease","volume":"37","author":"Piperi","year":"2004","journal-title":"Clin. Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-201X.2002.01021.x","article-title":"Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women","volume":"176","author":"Horter","year":"2002","journal-title":"Acta Physiol. Scand."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/01.ATV.14.7.1146","article-title":"HDL and plasma phospholipids in coronary artery disease","volume":"14","author":"Kunz","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/pr500061n","article-title":"NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease","volume":"13","author":"Kostara","year":"2014","journal-title":"J. Proteome Res."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/4\/721\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:35:46Z","timestamp":1760121346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/4\/721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":120,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["diagnostics13040721"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13040721","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}